Inventera
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Inventera develops tiny particles, on the scale of a billionth of a metre, designed to carry drugs precisely to diseased tissue inside the body, improving treatment effectiveness while reducing side effects.
Its core platform, called Invinity™, uses polysaccharide-based (naturally derived sugar-chain polymer) nanostructures engineered to stay stable in the bloodstream and reach target sites without being cleared by the immune system. The company is listed on KOSDAQ, South Korea's tech and small-cap exchange, and its work is directed at unmet medical needs where existing drugs fall short.
Summary is AI-generated and may contain errors · figures from DART filings
Inventera in five facts
What does Inventera do?
Inventera develops tiny particles, on the scale of a billionth of a metre, designed to carry drugs precisely to diseased tissue inside the body, improving treatment effectiveness while reducing side effects.
Where is Inventera listed and in which sector?
Inventera (Korean name: 인벤테라) trades under KRX code 0007J0 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Commercial Services.
How large is Inventera?
Its market capitalisation was US$54.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Inventera's latest annual revenue and operating profit?
For fiscal year 2025, Inventera reported revenue of US$0, an operating loss of US$6.5M and a net loss of US$6.1M, per its annual report on DART (data retrieved from DART on 2026-10-02).
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.